CD8A and cancer: Our results reveal proximity between CD8+ T cells to cancer cells and macrophages to cancer cells as candidate biomarkers for response to pre-operative combination ICIs, which have been thus far unexplored and provide a complementary view of the TME that warrants further investigation.